BioInvent International Financials
| BINV Stock | SEK 44.60 1.10 2.41% |
BioInvent |
Understanding current and past BioInvent International Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioInvent International's financial statements are interrelated, with each one affecting the others. For example, an increase in BioInvent International's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in BioInvent International's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioInvent International AB. Check BioInvent International's Beneish M Score to see the likelihood of BioInvent International's management manipulating its earnings.
BioInvent International Stock Summary
BioInvent International competes with Hansa Biopharma, Saniona AB, Active Biotech, Oncopeptides, and Cantargia. BioInvent International AB focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, and internationally. The Company was founded in 1997 and is based in Lund, Sweden. BioInvent International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 68 people.| Foreign Associates | |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0015244520 |
| Business Address | The Gamma Building, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.bioinvent.com |
| Phone | 46 4 62 86 85 50 |
| Currency | SEK - Swedish Kronor |
You should never invest in BioInvent International without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of BioInvent Stock, because this is throwing your money away. Analyzing the key information contained in BioInvent International's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
BioInvent International Key Financial Ratios
BioInvent International's financial ratios allow both analysts and investors to convert raw data from BioInvent International's financial statements into concise, actionable information that can be used to evaluate the performance of BioInvent International over time and compare it to other companies across industries.| Return On Equity | -0.0274 | |||
| Return On Asset | -0.0192 | |||
| Target Price | 81.0 | |||
| Number Of Employees | 93 | |||
| Beta | 0.3 |
BioInvent Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioInvent International's current stock value. Our valuation model uses many indicators to compare BioInvent International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioInvent International competition to find correlations between indicators driving BioInvent International's intrinsic value. More Info.BioInvent International AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioInvent International's earnings, one of the primary drivers of an investment's value.BioInvent International Systematic Risk
BioInvent International's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioInvent International volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on BioInvent International correlated with the market. If Beta is less than 0 BioInvent International generally moves in the opposite direction as compared to the market. If BioInvent International Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioInvent International is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioInvent International is generally in the same direction as the market. If Beta > 1 BioInvent International moves generally in the same direction as, but more than the movement of the benchmark.
BioInvent International November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioInvent International help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioInvent International AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioInvent International AB based on widely used predictive technical indicators. In general, we focus on analyzing BioInvent Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioInvent International's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.6 | |||
| Information Ratio | 0.0433 | |||
| Maximum Drawdown | 22.23 | |||
| Value At Risk | (5.57) | |||
| Potential Upside | 5.99 |
Additional Tools for BioInvent Stock Analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.